阿德福韦酯在乙型肝炎失代偿期肝硬化抗病毒治疗的研究进展

周学斌; 周建; 肖绍树

阿德福韦酯在乙型肝炎失代偿期肝硬化抗病毒治疗的研究进展

1. 大冶市人民医院消化内科
2. 黄石市五医院

详细信息

中图分类号: R512.62;R575.2
计量
- 文章访问数: 1941
- HTML全文浏览量: 3
- PDF下载量: 819
- 被引次数: 0
出版历程
- 出版日期: 2009-06-20

摘要

HTML全文

参考文献(22)

[1]杨清, 龚作炯, 胡丹凤.阿德福韦酯和拉米夫定治疗乙型肝炎肝硬化失代偿期临床观察[J].中华肝脏病杂志, 2007, 15∶821-824。

[2]肖绍树, 贺降福, 孙秋萍, 等.阿德福韦酯联合脾部分栓塞治疗乙型肝炎肝硬化并脾功能亢进的疗效研究[J]。中华临床医师杂志 (电子版) , 2008, 2 (7) ∶32-34.

[3] 中华医学会。慢性乙型肝炎防治指南[J].中华肝脏病杂志, 2005, 13∶881-891.

[4] 中华肝病杂志编辑部.慢性乙型肝炎抗病毒治疗重在规范:口服核苷 (酸) 类似药物的临床应用原则[J].中华肝病杂志, 2008, 16 (5) ∶335-340.

[5]Keeffe EB, Dieteich DT, Han SH, et al.A treatment algorithm for the management of chronic hepatitis B virus infection in the United states:an update[J].Clin Gastroenterol Hepatol, 2006, 4 (8) ∶936-962.

[6]Lok A, Mcmahon BJ.Chronic hepatitis B:AASLD practice guide-lines[J].Hepatology, 2007, 45∶507-539.

[7]Hoofnagle JH, Doo E, Liang TJ, et al.Management of Hepatitis B:Summarg of a Clinicalresearch workshop[J].Hepatology, 2007, 45∶1056-1075.

[8]Hoofnagle JH, Doo E, Liang TJ, et al.Management of Hepatitis B:Summarg of a Clinical research workshop[J].Hepatology, 2007, 45∶1056-1075.

[9]肖绍树, 贺降福, 胡志勇, 等.乙型肝炎肝硬化并脾部分栓塞术后阿德福韦酯疗效分析[J].中华实验临床感染病杂志 (电子版) 2009, 3 (2) ∶32-34.

[10]Marcelline P, Chang TT, Lim SG, et al.Adefovir dipivoxil for the treatment of hepatitis B eantigen-positive chronic hepatitis B[J].Nengl J Med, 2003, 348 (9) ∶808-816.

[11]Westland CE, Yang H, Delaney WE, et al.Activity of adefovir dip-ivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients[J].J Viral Hepat, 2005, 12 (1) ∶67-73.

[12]蔡皓东, 马季云, 曹传梅.阿德福韦酯治疗失代偿期慢性乙型肝炎九例[J].中华传染病杂志, 2006, 24∶413-414.

[13]Schiff ER, Lai CL, Hadziyannis S, et al.Adefovir dipivoxil therapg for lamivudine-resistant hepatitis B in pre-and post-Liver trans-plantation patients[J].Hepatology, 2003, 38∶1419-1427.

[14]Kim KM, Choi WB, Lim YS, et al.Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus[J].J Kore-an Med Sci, 2005, 20 (5) ∶821-828.

[15]任红.慢性乙型肝炎的抗病毒治疗:单药治疗还是联合治疗[J].中华肝脏病杂志, 2008, 16∶401-403.

[16]Liaw YF.2008APASL guidelines for HBV management/The18th Conference of the Asian pacific Association of the Liver[DB/OL], Seoul, 2008, http://www.apasl info/guidelines HBV.html.

[17]Angus PW, Patterson SJ.Liver transplantation for hepatitis B:what is the best hepatitis B immune globulin/antiviral regimen[J]-Liver Transpl, 2008, 14Suppl2:S15-22.

[18]杨丹红, 谢世峰, 王英民, 等.拉米夫定联合阿德福韦酯治疗乙型肝炎肝硬化的病毒应答[J].中华肝脏病杂志, 2008, 16∶473-539.

[19]Lok AS, Mcmahon BJ.Chronic hepatitis B[J].Hepatology, 2007, 45 (2) ∶507-539.

[20]茅益民, 曾民德。抗乙型病毒性肝炎新药——阿德福韦酯[J].中华肝脏病杂志, 2004, 12∶61-63.

[21]李东复, 金珍婧, 陈永胜, 等.阿德福韦酯治疗乙型肝炎肝硬化并乙型肝炎病毒相关性肾炎的近期疗效[J]。中华肝脏病杂志, 2008, 16∶349-351.

[22]Mao YM, Zeng MD.Adefovir dipivoxil-a new drug for hepatitis B[J].Zhonghua Ganzangbing Zazhi, 2004, 12 (1) ∶61-63.

施引文献

资源附件(0)

访问统计